share_log

Rapport Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Johnson & Johnson(6.8%),Johnson & Johnson Innovation-JJDC, Inc.(6.8%)

SEC ·  Oct 19, 2024 05:25
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more